TMVR (REC)
Rapid screening with interpretable reports
Annular sizing, device oversizing and more
Automated neo-LVOT with comparison across device sizes
IFU-based or customizable criteria
Regulatory: Research Only
Clinical Applications: Mitral Regurgitation
Modality: CT
Automated pre-screening measurements with ICCs between 0.80 - 0.94 [Read Publication]
Segmentation dice scores between 0.94-0.98 [Full AI Performance]
TMVR (REC)
Rapid screening with interpretable reports
Annular sizing, device oversizing and more
Automated neo-LVOT with comparison across device sizes
IFU-based or customizable criteria
Regulatory: Research Only
Clinical Applications: Mitral Regurgitation
Modality: CT
Automated pre-screening measurements with ICCs between 0.80 - 0.94 [Read Publication]
Segmentation dice scores between 0.94-0.98 [Full AI Performance]
Latest News
REC Pre-Screening resulted in "reliable anatomical measurements" and "good accuracy compared to Abbott core lab decision making" for Tendyne, presented by Dr. Jonathan Curio (University Hospital Cologne).
4th June 2024, New York Valves
Press Release: LARALAB GmbH Launches Groundbreaking New Product 'REC - Rapid Eligibility Check'.
13th May, 2024
04 / 2025
Curio, Jonathan et al.
10 / 2024
Beyer, Martin et al.